At CICATRIALS® we invite you to conduct your studies in Mexico and LATAM, because we can provide you different competitive offers that will allow you to achieve your objectives successfully and in record time.
- Great diversity of inhabitants.
- The health systems offer a variety of options for clinical research since the public and private sectors consider different conditions of care.
- Qualified sites for clinical research, hospital infrastructure and systems for medical monitoring of patients.
The local regulatory framework establishes criteria for the execution of research projects for human health.
- It is an inclusive regulation that allows all the research phases to be carried out, as well as applying innovative models and designs.
- Low costs in the organization and conduct of clinical studies.
And there is more:
- Experience in conducting protocols in multiple therapeutic areas and a diverse epidemiological profile that leads to communicable, noncommunicable and co-degenerative diseases, as well as rare diseases.
- Researchers trained according to the most demanding regulatory standards and with experience in all therapeutic areas (infants, adults and seniors).
- According to current regulations, if an investigation includes Mexican patients in the study, Mexico has the possibility of being the first country in the world to authorize the registration of a molecule and device.
- Countries such as Colombia, Panama, Argentina, Peru, and Mexico already have electronic systems for submitting protocols, which accelerate regulatory times.